Agreed; my point is not that worldwide HCV sales will climb to $71B (as the market-research-company claims), but rather that they will not fall off a cliff, as many investors currently think.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”